Associations between expression levels of nine core nucleotide excision repair genes in lymphocytes and risk of head and neck squamous cell carcinomas in a Chinese population
- PMID: 31832883
- DOI: 10.1007/s10147-019-01586-9
Associations between expression levels of nine core nucleotide excision repair genes in lymphocytes and risk of head and neck squamous cell carcinomas in a Chinese population
Abstract
Background: Head and neck squamous cell carcinomas (HNSCCs) are one of the most common cancers in the world, and nucleotide excision repair (NER) is involved in HNSCCs susceptibility. We investigated whether mRNA expression levels of nine core NER genes were associated with risk of HNSCCs in a Chinese population.
Methods: In this study of 251 HNSCC patients and 232 healthy controls, we quantified NER gene mRNA expression levels in cultured peripheral lymphocytes using a quantitative real-time PCR.
Results: Compared with the controls, HNSCC patients had statistically significantly lower expression levels of XPA and XPB (P = 0.029 and 0.001, respectively). After dividing the subjects by the controls' median values of expression levels, we found a dose-dependent association between an increased risk of HNSCCs and low expression levels of XPB (adjusted OR 1.56 and 95% CI 1.07-2.28; Ptrend = 0.001). We also identified a significant multiplicative interaction between smoking status as well as alcohol status and mRNA expression levels of XPB (P = 0.014 and 0.042, respectively). Finally, after integrating demographic variables, we found the addition of smoking status and XPB expression levels to the model significantly improved the sensitivity of the expanded model on HNSCC risk.
Conclusion: Reduced mRNA expression levels of XPB were associated with an increased risk of HNSCCs in a Chinese population.
Keywords: Cancer susceptibility; DNA repair; HNSCCs; NER genes; mRNA.
Similar articles
-
Combining Phenotypes of Nucleotide Excision Repair Pathway to Predict the Risk of Head and Neck Squamous Cell Carcinomas in a Chinese Population.Dis Markers. 2022 Sep 7;2022:4959737. doi: 10.1155/2022/4959737. eCollection 2022. Dis Markers. 2022. PMID: 36118674 Free PMC article.
-
Reduced mRNA expression of nucleotide excision repair genes in lymphocytes and risk of squamous cell carcinoma of the head and neck.Carcinogenesis. 2017 May 1;38(5):504-510. doi: 10.1093/carcin/bgx028. Carcinogenesis. 2017. PMID: 28379545 Free PMC article.
-
Associations between expression levels of nucleotide excision repair proteins in lymphoblastoid cells and risk of squamous cell carcinoma of the head and neck.Mol Carcinog. 2018 Jun;57(6):784-793. doi: 10.1002/mc.22801. Epub 2018 Mar 25. Mol Carcinog. 2018. PMID: 29528139 Free PMC article.
-
XPB: An unconventional SF2 DNA helicase.Prog Biophys Mol Biol. 2015 Mar;117(2-3):174-181. doi: 10.1016/j.pbiomolbio.2014.12.005. Epub 2015 Jan 30. Prog Biophys Mol Biol. 2015. PMID: 25641424 Review.
-
Polymorphisms in human DNA repair genes and head and neck squamous cell carcinoma.J Genet. 2012;91(3):375-84. doi: 10.1007/s12041-012-0193-z. J Genet. 2012. PMID: 23271025 Review.
Cited by
-
XPA: DNA Repair Protein of Significant Clinical Importance.Int J Mol Sci. 2020 Mar 22;21(6):2182. doi: 10.3390/ijms21062182. Int J Mol Sci. 2020. PMID: 32235701 Free PMC article. Review.
-
Combining Phenotypes of Nucleotide Excision Repair Pathway to Predict the Risk of Head and Neck Squamous Cell Carcinomas in a Chinese Population.Dis Markers. 2022 Sep 7;2022:4959737. doi: 10.1155/2022/4959737. eCollection 2022. Dis Markers. 2022. PMID: 36118674 Free PMC article.
-
DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival.Int J Mol Sci. 2023 Feb 1;24(3):2760. doi: 10.3390/ijms24032760. Int J Mol Sci. 2023. PMID: 36769087 Free PMC article. Review.
-
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma.Int J Mol Sci. 2022 Jul 28;23(15):8360. doi: 10.3390/ijms23158360. Int J Mol Sci. 2022. PMID: 35955506 Free PMC article.
-
Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma.Front Oncol. 2022 Oct 21;12:1031944. doi: 10.3389/fonc.2022.1031944. eCollection 2022. Front Oncol. 2022. PMID: 36338767 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical